News

Latest industry coverage

All India World

Most watched

Google News

PharmTech.com

Drapeau’s AI Deep Dive: The Control Lab Tested for Flavor

PR Newswire

Xtalks Announces its Life Science Webinar Calendar for October 2026

businesswire.com

McKesson Corporation Extends Pharmaceutical Distribution Agreement with CVS Health

MIT Sloan Management Review

Takeda Pharmaceutical: Reimagining R&D With AI

Yahoo! Finance Canada

PharmaTher Enters into Exclusive North American Distribution Agreement with Craft Health for CraftMake(TM) Pharmaceutical 3D Printing Platform

PharmaShots

Oct 1, 2026, 12:30 PM

BI Reports P-III (SYNCHRONIZE-2) Trial Data on Survodutide for Obesity/Overweight and Type 2 Diabetes at EASD 2026

Shots: Ref: Globenewswire | Image: Boehringer Ingelheim | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post BI Reports P-III (SYNCHRONIZE-2) Trial Data on Survodutide for Obesity/Overweight and Type 2 Diabetes at EASD 2026 appeared first on PharmaShots.

PharmaShots

Oct 1, 2026, 11:30 AM

BMS Reports US FDA Approval of Camzyos in Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)

Shots: Ref: Businesswire | Image: BMS | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post BMS Reports US FDA Approval of Camzyos in Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) appeared first on PharmaShots.